Royal Bank of Canada
DMRA

Royal Bank of Canada’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Royal Bank of Canada’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+7
New +$180 ﹤0.01% 7337
2024
Q3 		– Sell
-8
Closed – – 7067
2024
Q2 		$0 Buy
8
+5
+167% +$79 ﹤0.01% 7232
2024
Q1 		$0 Sell
3
-1
-25% -$18 ﹤0.01% 7222
2023
Q4 		$0 Buy
+4
New +$62 ﹤0.01% 7293

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Royal Bank of Canada's DMRA Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7337 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in DMRA as recently as Q2 2024.

Royal Bank of Canada first reported a position in DMRA in Q4 2023 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Royal Bank of Canada held 7 shares of Damora Therapeutics, Inc. Ordinary Shares worth $0 as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Royal Bank of Canada position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7337 holding.
  • Royal Bank of Canada first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2023 and has held it in 4 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.